GP-Act III Acquisition’s (NASDAQ:GPATU – Get Free Report) lock-up period is set to expire on Tuesday, November 5th. GP-Act III Acquisition had issued 25,000,000 shares in its IPO on May 9th. The total size of the offering was $250,000,000 based on an initial share price of $10.00. After the expiration of GP-Act III Acquisition’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.
GP-Act III Acquisition Stock Performance
Shares of NASDAQ GPATU opened at $10.11 on Tuesday. GP-Act III Acquisition has a one year low of $10.02 and a one year high of $11.99. The firm has a fifty day moving average price of $10.20.
Institutional Trading of GP-Act III Acquisition
Several hedge funds and other institutional investors have recently bought and sold shares of GPATU. Highbridge Capital Management LLC acquired a new position in GP-Act III Acquisition in the 2nd quarter valued at $100,000. TrueMark Investments LLC bought a new stake in GP-Act III Acquisition during the second quarter worth about $178,000. Condor Capital Management acquired a new stake in GP-Act III Acquisition during the second quarter worth about $196,000. Sea Otter Advisors LLC acquired a new stake in GP-Act III Acquisition during the second quarter worth about $501,000. Finally, Shaolin Capital Management LLC bought a new position in GP-Act III Acquisition in the 2nd quarter valued at about $1,003,000.
GP-Act III Acquisition Company Profile
GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp.
See Also
- Five stocks we like better than GP-Act III Acquisition
- The Role Economic Reports Play in a Successful Investment Strategy
- Intel: Is Now the Time to Be Brave?
- How Can Investors Benefit From After-Hours Trading
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Are Trending Stocks? Trending Stocks Explained
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.